Current Value of Holding

$24 Million

Shares

56.8 Thousand

% of Portfolio

0.55%

Average Buy Price

$389

Avg closing price
Price range

8 Jefferies Group Vertex Pharmaceuticals Trades

Jefferies Group acquired 56.8 Thousand Vertex Pharmaceuticals shares worth $24 Million. That's 0.55% of their equity portfolio (36th largest holding). The first Vertex Pharmaceuticals trade was made in Q1 2016. Since then Jefferies Group bought shares four more times and sold shares on three occasions. The stake costed the investor $22.1 Million, netting the investor a gain of 8.6% so far.

Avg closing price
Price range
Increased shares by 215.5% (+38.8 Thousand shares) Q1 2024
Avg closing price $422.74
Price range $407.69 - $446.08
Increased shares by 5882.7% (+17.7 Thousand shares) Q4 2023
Avg closing price $369.42
Price range $343.00 - $410.68
Sold 97.2% shares (-10.6 Thousand shares) Q3 2023
Avg closing price $349.73
Price range $338.18 - $362.46
Sold 1.7% shares (-191 shares) Q2 2023
Avg closing price $336.94
Price range $314.42 - $351.91
Increased shares by 48.6% (+3.64 Thousand shares) Q1 2023
Avg closing price $299.93
Price range $283.23 - $323.10
New holding (+7.49 Thousand shares) Q4 2022
Avg closing price $304.77
Price range $285.76 - $321.48
Sold -3.3 Thousand shares Q2 2016
Avg closing price $86.41
Price range $79.15 - $96.09
New holding (+3.3 Thousand shares) Q1 2016
Avg closing price $90.45
Price range $78.40 - $123.45

News about Vertex Pharmaceuticals, Inc. and Jefferies Group

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!